Centre for the AIDS Programme of Research in South Africa (CAPRISA)
Abdool Karim, an infectious diseases epidemiologist and Associate Scientific Director of the Centre for the Aids Programme of Research in South Africa (CAPRISA), focuses her research on the evolution of the human immunodeficiency virus (HIV), factors influencing HIV acquisition, development and evaluation of interventions to prevent HIV infection in young women; novel strategies to introduce AIDS treatment in high disease-burden settings and Covid-19. Her landmark 'CAPRISA 004 tenofovir gel' study provided the first evidence of the use of antiretrovirals to prevent HIV infection, published in "Science". Abdool Karim is a Professor in Clinical Epidemiology at Columbia University, USA, pro-Vice Chancellor African Health at University of KwaZulu-Natal, South Africa. Her more than 30 awards include the 2014 TWAS-Lenovo Prize; the South Order of Mapungubwe, the 2016 L'Oreal-UNESCO International Award for Women in Science for Africa and the Arab States region, the 2020 John Dirks-Gairdner Global Health Award, 2021 Christophe Merieux Prize from the French Academies of Science, Special VinFuture Prize for Developing Country Innovators, 4th Hideyo Noguchi Africa Prize for Medical Research.
Sustainable Development Goals:
3 - Good health and well-being
4 - Quality education
5 - Gender equality
Section:04-Medical and Health Sciences incl. Neurosciences